Avizakimab, formerly known as BOS161721, represents a novel therapeutic approach to treating inflammatory conditions . This biological medication selectively targets interleukin-18 , a vital protein https://kalektwz607251.blognody.com/50408045/avizakimab-a-detailed-analysis-into-bos161721-s-promise